Silicon Valley BioTalks: Setting Up Early State Clinical Trials
June 1, 2016 - Palo Alto
With 17% of registered clinical trials being early phase studies, we asked experts from the sponsor and CRO worlds to share their knowledge on how to best set up and manage early stage clinical trials to meet this difficult environment. They will explore some of the challenges small and start-up biotechs face when launching clinical development programs.
This website uses cookies to ensure you get the best experience on our website. Learn more